Skip to main content

Hyperuricemia & Gout Clinical Trials

Living with the Challenges of ANCA-Associated Vasculitis?

Exploring Potential Treatment Options for ANCA-Associated Vasculitis

ANCA-Associated Vasculitis (AAV) is a rare autoimmune condition where the immune system mistakenly attacks blood vessels, causing inflammation and damage to organs such as the kidneys, lungs, nerves, and sinuses. Without proper management, AAV can lead to serious health complications. Clinical trials are helping explore potential new treatment options and improve quality of life for those living with this condition.

Revive Research Institute is conducting ANCA-Associated Vasculitis clinical trials in Michigan to explore investigational treatment options that may help prevent infection and recurrence.

To be eligible for ANCA-Associated Vasculitis clinical trials in Michigan, participants must:

  1. Adults aged 18 years or older
  2. Diagnosed with Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA)

*Additional criteria may apply.

*Take part in paid ANCA-Associated Vasculitis Clinical Trials at no cost to you or your medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related care from an experienced research team.

*If you are interested in participating in the ANCA-Associated Vasculitis Clinical Trials in Sterling Heights, Michigan or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
For more info, please visit Privacy Policy.

About the Clinical Trials for ANCA-Associated Vasculitis

ANCA-Associated Vasculitis (AAV) is a rare autoimmune disease in which the immune system mistakenly attacks small blood vessels, leading to inflammation and potential damage to vital organs such as the kidneys, lungs, nerves, and sinuses. Symptoms can vary widely, but may include fatigue, shortness of breath, joint pain, and kidney problems.

Because AAV can be unpredictable and difficult to manage, many people continue to experience relapses or complications despite current treatments. That’s why ANCA-Associated Vasculitis research studies are essential—to help uncover new therapies that may better control inflammation, prevent relapses, and improve quality of life.

ANCA-Associated Vasculitis Clinical Trials will be conducted in several locations across the United States, including Michigan. To ensure eligibility, participants must meet specific study criteria and comply with study procedures. These studies aim to evaluate the safety and effectiveness of an investigational treatment compared to standard therapy for people living with AAV.

*There is no cost to you, your private medical insurance, or the public health insurance plan for study procedures. The study-related procedures, and visits will be provided at no charge throughout the duration of the study.

Get Started: What to Expect?

If you qualify for an ANCA-Associated Vasculitis Clinical Trial in Michigan, you may have access to potential treatment options that target this infection. After completing the interest from above, a research team member will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you will be invited to a screening visit at our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in ANCA-Associated Vasculitis Clinical Trials.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask any questions before enrolling. Your participation helps advance future treatments for ANCA-Associated Vasculitis.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

Length of study

Approx. 104 weeks

Number of study visits

Approx. 20 visits

Location

Michigan

Understanding ANCA-Associated Vasculitis

ANCA-Associated Vasculitis (AAV) is a rare autoimmune disorder in which the immune system mistakenly attacks small blood vessels, causing inflammation and damage to organs and tissues. It is estimated that thousands of people across the United States are affected by this condition each year.

Common symptoms of ANCA-Associated Vasculitis include:

  • Persistent fatigue or weakness
  • Shortness of breath or coughing due to lung involvement
  • Sinus pain, nasal congestion, or frequent nosebleeds
  • Joint or muscle pain
  • Blood in urine or swelling in the legs (signs of kidney involvement)

For some individuals, symptoms may appear suddenly and severely, while for others, they develop gradually over time. Without proper management, AAV can lead to long-term organ damage, particularly in the kidneys and lungs. Early diagnosis and treatment are essential to help control inflammation, prevent relapses, and protect overall health.

Frequently Asked Questions (FAQs)

1. What is ANCA-Associated Vasculitis (AAV)?

AAV is a group of rare autoimmune diseases where the immune system attacks small blood vessels, leading to inflammation and damage in organs such as the kidneys, lungs, and sinuses.

2. What causes ANCA-Associated Vasculitis?

The exact cause is unknown, but it’s believed to involve a combination of genetic, environmental, and immune system factors. Certain infections, medications, or exposure to environmental triggers like silica dust may increase risk.

3. What are the common symptoms of AAV?

Symptoms vary depending on the organs affected but often include fatigue, joint pain, sinus inflammation, shortness of breath, coughing, and blood in urine.

4. How is ANCA-Associated Vasculitis diagnosed?

Diagnosis typically involves blood tests for ANCA antibodies, urine tests, imaging studies, and sometimes tissue biopsy to confirm vessel inflammation.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com